Bone Marrow Transplant Evaluation at Karolinska University Hospital

Bone Marrow Transplant Evaluation at Karolinska University Hospital provides specialist assessment for patients who may require bone marrow or hematopoietic stem cell transplantation. The evaluation helps determine whether transplantation may be appropriate based on the underlying disease, treatment history, disease status, overall health, organ function, and potential transplant risks and benefits.

Price

Price on Request

Why Price on Request?

The cost of a bone marrow transplant evaluation varies depending on the patient's diagnosis, laboratory and diagnostic investigations, organ-function assessments, donor requirements, specialist consultations, and additional testing. A personalized cost estimate can be provided after appropriate medical review.

Complete Description

What Is a Bone Marrow Transplant Evaluation?

A bone marrow transplant evaluation is a comprehensive specialist assessment used to determine whether a patient may be suitable for hematopoietic stem cell transplantation.

The evaluation considers the patient's disease, previous treatments, overall health, transplant goals, and potential risks before a treatment pathway is recommended.

Assessment of the Underlying Disease

The transplant team reviews the patient's diagnosis and current disease status to determine whether transplantation may provide an appropriate treatment option.

Blood cancers, bone marrow disorders, and other serious hematological conditions may require different transplant strategies.

Review of Previous Treatment

Previous chemotherapy, targeted treatment, immunotherapy, radiation therapy, transplantation, or other treatments may influence transplant planning.

Medical records are reviewed to understand treatment response, previous complications, and the patient's current clinical status.

Disease Status and Transplant Timing

The timing of transplantation can depend on the type of disease, response to previous treatment, risk characteristics, and overall health.

The transplant team may assess whether transplantation should be considered immediately, after additional treatment, or whether another management approach may be more appropriate.

Medical and Physical Assessment

A detailed medical assessment may include review of symptoms, previous illnesses, medications, surgeries, infections, and other relevant health factors.

The patient's physical condition and ability to tolerate intensive treatment are important parts of transplant eligibility assessment.

Organ Function Assessment

Before transplantation, the medical team may evaluate heart, lung, kidney, liver, and other organ functions.

These assessments help identify medical factors that could influence transplant safety and treatment planning.

Laboratory and Diagnostic Testing

Depending on the patient's condition, evaluation may include blood tests, bone marrow studies, imaging, pathology, infection screening, and other diagnostic investigations.

The required tests are determined according to the patient's diagnosis and proposed transplant approach.

Donor Evaluation

For an allogeneic transplant, the availability and suitability of a donor are important considerations.

Potential donors may undergo compatibility testing and medical assessment to determine whether they can safely provide stem cells.

HLA and Compatibility Assessment

Human leukocyte antigen, or HLA, compatibility testing may be used when evaluating potential donors.

The transplant team considers compatibility results together with donor availability and other clinical factors when assessing transplant options.

Autologous Transplant Assessment

Some patients may be evaluated for autologous transplantation, which uses their own collected stem cells.

Suitability depends on the underlying disease, previous treatment, overall health, and the planned treatment strategy.

Allogeneic Transplant Assessment

Allogeneic transplantation uses stem cells from another person, such as a related or unrelated donor.

The evaluation considers disease status, donor compatibility, overall health, previous treatment, and the potential benefits and risks of transplantation.

Infection and Immunity Assessment

Patients may undergo screening for infections and other conditions that could affect transplantation.

The results can help the medical team plan preventive measures and supportive treatment before and after transplantation.

Transplant Risk Assessment

The transplant team evaluates potential risks associated with conditioning treatment, transplantation, infection, organ complications, graft-versus-host disease, and other possible complications.

This assessment supports informed treatment planning.

Individualized Transplant Planning

Following evaluation, the transplant team may recommend a specific transplant strategy, additional investigations, further disease treatment, or an alternative approach.

The final plan depends on the patient's individual clinical circumstances.

Second Opinion

Patients who have already been advised to undergo bone marrow transplantation may seek an independent specialist assessment.

Review of previous diagnostic results, treatment history, donor information, and transplant recommendations can provide an additional clinical perspective.

International Patient Care

International patients may be considered for bone marrow transplant evaluation subject to applicable eligibility, referral, appointment, and hospital requirements.

Medical records, pathology reports, laboratory results, imaging studies, treatment history, and donor information may be requested before assessment.

Benefits of Bone Marrow Transplant Evaluation

• Comprehensive transplant eligibility assessment

• Review of the underlying blood or bone marrow disorder

• Assessment of previous treatment and disease response

• Evaluation of organ function and overall health

• Donor and compatibility assessment when required

• Review of autologous and allogeneic transplant options

• Identification of potential transplant-related risks

• Individualized treatment and transplant planning

Why Choose Karolinska University Hospital?

Karolinska University Hospital provides specialist hematology and transplant assessment within an academic healthcare environment. Patients being considered for bone marrow transplantation may benefit from multidisciplinary expertise, detailed diagnostic evaluation, donor assessment, and individualized transplant planning.

Cost & Price on Request

The overall cost depends on the patient's underlying condition, diagnostic investigations, laboratory testing, donor assessment, specialist consultations, and additional medical requirements.

Because evaluation needs differ between patients, this service is offered at Price on Request following appropriate medical review.

Frequently Asked Questions

Who may require a bone marrow transplant evaluation?

Patients with selected blood cancers, bone marrow disorders, or other serious hematological conditions may be evaluated when stem cell transplantation is being considered as part of treatment.

What is assessed before a bone marrow transplant?

The evaluation may include disease status, previous treatment, overall health, organ function, laboratory results, infection status, and donor compatibility when an allogeneic transplant is being considered.

What is the difference between autologous and allogeneic transplantation?

Autologous transplantation uses the patient's own stem cells, while allogeneic transplantation uses stem cells from a suitable donor.

Does a transplant evaluation guarantee that transplantation will be performed?

No. The evaluation determines whether transplantation may be appropriate. The final decision depends on the patient's diagnosis, health, treatment response, donor availability, risks, and specialist assessment.

Can international patients receive a bone marrow transplant evaluation at Karolinska University Hospital?

International patients may be considered subject to applicable eligibility, referral, appointment, and hospital requirements. Comprehensive medical records may be required for specialist assessment.

Product Details

Product Name: Bone Marrow Transplant Evaluation at Karolinska University Hospital
Hospital: Karolinska University Hospital
Brand: Karolinska University Hospital
Country: Sweden
Location: Stockholm, Sweden
Specialty: Hematology & Blood Disorders
Service Type: Bone Marrow Transplant Evaluation
Customer-Facing Price: Price on Request
International Patients: Subject to applicable eligibility and appointment requirements